• Mashup Score: 0

    Dr. Dean is interested in inherited (germline) genetic variation, somatic mutations in tumors, and the combined effect of both on cancer risk, progression, and response to therapy. He also investigates the genetic components of cancer health disparities in the U.S. and in Latin America.

    Tweet Tweets with this article
    • Dr. Michael Dean studies variation in #HPV and its impact when it integrates into the genome of #CervicalCancer cells. #HPVAwarenessDay #NCI_LTG https://t.co/bTI1yNOzCB

  • Mashup Score: 0

    Ludmila Prokunina-Olsson, Oscar Florez-Vargas in the Laboratory of Translational Genomics and their colleagues performed genetic and functional studies and found that interferon treatment may improve COVID-19 outcomes in people who carry a particular set of genetic variants in the OAS1 gene.

    Tweet Tweets with this article
    • A 2022 study by @prokuninaolsson, @RoufDr, @oflorezvargas, and colleagues finds interferon treatment may reduce the severity of COVID-19 in people who carry certain genetic variants in the OAS1 gene. #DCEGBestOf2022 @NatureGenet #NCI_LTG https://t.co/wdFX26ERhO

  • Mashup Score: 2

    Dr. Jun Zhong focuses his research on identifying inherited variants associated with risk of pancreatic cancer using various genome-wide approaches, understanding the biology of germline risk variants using genomic technologies, and identifying non-coding somatic mutations that drive pancreatic carcinogenesis.

    Tweet Tweets with this article
    • Happening Now: @DrJZhong in #NCI_LTG is presenting "Identifying non-coding somatic driver mutations in regulatory elements for pancreatic cancer" at #ASHG22 @GeneticsSociety https://t.co/ZkArg5z1BS

  • Mashup Score: 0

    Dr. Rebecca Hennessey utilizes screening methods to functionally characterize multiple and complex melanoma susceptibility loci that were identified via genome-wide association studies.

    Tweet Tweets with this article
    • Happening Now: Dr. Rebecca Hennessy in #NCI_LTG is presenting "Comprehensive CRISPR-based dissection of a complex common and familial melanoma risk locus on chromosome band 9p21." [Board No. PB1052] at #ASHG22 @GeneticsSociety https://t.co/RuKrF6198l

  • Mashup Score: 0

    Dr. Erping Long conducts research that leverages computational approaches and large-scale functional genomics resources to understand genetic susceptibility to lung cancer and melanoma.

    Tweet Tweets with this article
    • Happening Now: Dr. @ErpingLong in #NCI_LTG is presenting "Massively parallel reporter assays with multi-layer annotations identified cell-type-specific functional variants and genes associated with melanoma" [Board No. PB2640] at #ASHG22 @GeneticsSociety https://t.co/CyMAUr0KBr

  • Mashup Score: 1

    A new study identified 85 genomic loci associated with cutaneous melanoma risk using an integrative approach based on genome-wide association studies and transcriptome association approaches. These findings were published in Nature Genetics on April 27, 2020.

    Tweet Tweets with this article
    • Study in @NatureGenet identified 85 genomic loci associated with cutaneous #melanoma risk using an integrative approach based on genome-wide association studies. https://t.co/tgqjDrgP0k #NCI_ITEB #NCI_LTG @mitchiela @kbrowngenetics @gomgomdr @NCIChanock #SummerSunSafety https://t.co/t953ec972x

  • Mashup Score: 6

    Ludmila Prokunina-Olsson, Oscar Florez-Vargas in the Laboratory of Translational Genomics and their colleagues performed genetic and functional studies and found that interferon treatment may improve COVID-19 outcomes in people who carry a particular set of genetic variants in the OAS1 gene.

    Tweet Tweets with this article
    • A new study by @prokuninaolsson, @RoufDr, @oflorezvargas and colleagues finds interferon treatment may reduce the severity of COVID-19 in people who carry certain genetic variants in the OAS1 gene. @NatureGenet #NCI_LTG https://t.co/wdFX26Ws9m